Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
ChEBI ID: 37598
Member | Definition | Role |
---|---|---|
4-hydroxycyclophosphamide | A phosphorodiamide that consists of 2-amino-1,3,2-oxazaphosphinan-4-ol 2-oxide having two 2-chloroethyl groups attached to the exocyclic nitrogen. | 4-hydroxycyclophosphamide |
4-ketocyclophosphamide | 4-Ketocyclophosphamide | |
aldophosphamide | Aldophosphamide | |
carboxyphosphamide | Carboxyphosphamide | |
chlorambucil | A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia. | chlorambucil |
mechlorethamine | mechlorethamine | |
mechlorethamine n-oxide | Nitrogen mustard N-oxide | |
melphalan | A phenylalanine derivative comprising L-phenylalanine having [bis(2-chloroethyl)amino group at the 4-position on the phenyl ring. | melphalan |
nornitrogen mustard | bis(2-chloroethyl)amine | |
perfosfamide | A phosphorodiamide that is the active metabolite of the nitrogen mustard cyclophosphamide. It has potent antineoplastic and immunosuppressive properties. | 4-hydroperoxycyclophosphamide |
phosphoramide mustard | phosphoramide mustard | |
uracil mustard | 5-[bis(2-chloroethyl)amino]uracil |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 8,463 (52.12) | 18.7374 |
1990's | 2,535 (15.61) | 18.2507 |
2000's | 2,270 (13.98) | 29.6817 |
2010's | 2,305 (14.20) | 24.3611 |
2020's | 663 (4.08) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 2,102 (11.56%) | 5.53% |
Reviews | 1,261 (6.93%) | 6.00% |
Case Studies | 2,115 (11.63%) | 4.05% |
Observational | 30 (0.16%) | 0.25% |
Other | 12,682 (69.72%) | 84.16% |